ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 130 filers reported holding ACCELERON PHARMA INC in Q1 2016. The put-call ratio across all filers is 3.66 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $232,000 | +6.9% | 6,400 | 0.0% | 0.08% | -9.2% |
| Q2 2016 | $217,000 | -30.4% | 6,400 | 0.0% | 0.09% | -1.1% |
| Q4 2015 | $312,000 | -87.0% | 6,400 | -91.6% | 0.09% | -61.2% |
| Q2 2015 | $2,405,000 | -20.0% | 76,000 | -3.8% | 0.23% | -20.1% |
| Q1 2015 | $3,007,000 | -6.7% | 79,000 | -4.5% | 0.28% | -8.1% |
| Q4 2014 | $3,222,000 | +28.1% | 82,700 | -0.6% | 0.31% | +18.8% |
| Q3 2014 | $2,516,000 | -20.5% | 83,200 | -10.6% | 0.26% | -4.4% |
| Q2 2014 | $3,163,000 | -1.2% | 93,100 | +0.3% | 0.27% | +4.2% |
| Q1 2014 | $3,202,000 | -13.8% | 92,800 | -1.1% | 0.26% | -14.4% |
| Q4 2013 | $3,714,000 | +91.0% | 93,800 | +7.2% | 0.30% | +68.5% |
| Q3 2013 | $1,945,000 | – | 87,500 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |